Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.50K$7.50Kderived±0.0% vs Q4 2023 Net Income-$999.09K-$999.09KderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$1,943N/M Operating Incomederived-$82,757N/M Operating Cash Flowderived-$406N/M Margins · derivedGross margin-25.9%−34.3 pt vs Q4 2023
Operating margin-1103.4%−262.4 pt vs Q4 2023
Net margin-13321.1%−12424.9 pt vs Q4 2023
ended May 31, 2024 · filed Sep 13, 2024 · 105 d after period end